Summary
The half-life and metabolic clearance rale (MCR) of antipyrine and phenytoin were determined in 14 young [mean age: 28.8 ± 8.3 (SD) years] and in 14 elderly [mean age: 83.5 ±7.1 (SD) years] subjects and correlated with liver volume, which was determined by ultrasonic scanning, to see if an age-dependent difference in drug metabolism could be explained by a reduced liver weight with age.
The size of the liver was smaller in the elderly subjects even when related to decreased body surface. A significant decrease in serum albumin in the elderly compared with the younger group was also noted. The half-life of antipyrine was significantly longer in the elderly than in the younger group, 756 ± 318 and 465 ± 110 minutes, respectively, and the MCR was correspondingly lower in the elderly even when calculated per litre of liver volume, 22.8 ± 7.8 and 36.3 ± 8.9ml/minute/L liver volume, respectively. No significant differences in the 2 age groups were found in half-life and total clearance of phenytoin, but a reduced free phenytoin clearance was demonstrated in the elderly (240 ± 92ml/minute/L liver volume) compared with the younger (325 ± 81 ml/minute/L liver volume) group. No significant correlation was found between liver volume and the half-life of antipyrine and phenytoin. However, a significant correlation was demonstrated between liver volume and MCR of antipyrine as well as between total and free clearance of phenytoin. No correlation was found between the half-lives of the 2 drugs, while a significant correlation existed between the clearance values.
It is suggested that the age-dependent reduction in drug clearance is due not only to a smaller liver volume, but is also a result of a reduced capacity of the liver microsomes per unit of liver in the elderly. With regard to age-dependent changes in drug metabolism, the protein binding of the actual drug has to be taken into consideration.
Similar content being viewed by others
References
Brien, J.F.; Inaba, T. and Kalow, W.: Comparative drug elimination in man — Diphenylhydantoin and amobarbital. European Journal of Clinical Pharmacology 9: 79–83 (1975).
Brodie, B.B.; Axelrod, J.; Soberman, R. and Levy, B.B.: Estimation of antipyrine in biological materials. Journal of Biological Chemistry 179: 25–29 (1949).
Castleden, C.M. and George, C.F.: The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54 (1979).
Cunningham, J. L.; Bullen, M.F. and Price Evans, D.A.: The pharmacokinetics of acetanilide and diphenylhydantoin sodium. European Journal of Clinical Pharmacology 7: 461–466 (1974).
Cuny, G.; Royer, R.J.; Mur, J.M.; Serot, J.M.; Faure, G.; Netter. P.; Maillard, A. and Penin, F.: Pharmacokinetics of salicylates in the elderly. Gerontology 25: 49–55 (1979).
Davies, D.S.; Thorgeirsson, S.S.; Breckenridge, A. and Orme, M.: Interindividual differences in rates of drug oxidation in man. Drug Metabolism and Disposition 1: 411–417 (1973).
Halliwell, M.; Homeida, M. and Roberts, C.J.C.: Value of liver volume measurement in the study of antipyrine kinetics in liver disease. British Journal of Clinical Pharmacology 4: 393P–394P (1977).
Hansen, J.M.; Kristensen, M.; Skovsted, L. and Christensen, L.K.: Dicoumarol induced diphenylhydantoin intoxication. Lancet 2: 265–266 (1966).
Hayes, M.J.; Langman, M.J.S. and Short, A.H.: Changes in drug metabolism with increasing age. I. Warfarin binding and plasma proteins. British Journal of Clinical Pharmacology 2: 69–72 (1975a).
Hayes, M.J.; Langman, M J.S. and Short, A.H.: Changes in drug metabolism with increasing age. II Phenytoin clearance and protein binding. British Journal of Clinical Pharmacology 2: 73–79 (1975b).
Houghton, G.W.; Richeas, A. and Leighton, M.: Effects of age, height, weight and sex on serum concentration in epileptic patients. British Journal of Clinical Pharmacology 2: 251–256 (1975).
Johnsen, S.G.; Kampmann, J.P.; Bennett, E.P. and Jørgensen, F.S.: Enzyme induction by oral testosterone. Clinical Pharmacology and Therapeutics 20: 233–237 (1976)
Jori, A.; DiSalle, E. and Quadri, A.: Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology 8: 273–279 (1972).
Kadar, D.; Inaba, T.; Endrenyi, L.; Hohnson, G.E. and Kalow, W.: Comparative drug elimination capacity in man —glulethimide, amobarbital, antipyrine and sulfinpyrazone. Clinical Pharmacology and Therapeutics 14: 552–560 (1973).
Kampmann, J.P.; Mortensen, H.B.; Bach, B.; Waldroff, S; Kristensen, M. and Hansen, J.M.: Kinetics of propylthiouracil in the elderly. Acta Medica Scandinavica 624 (Suppl.): 93–98 (1979).
Kato, R.; Vassanelli, P.; Frontino, G. and Chiesara, E.: Variation in activity of liver microsomal drug-metabolising enzymes in rats in relation to age. Biochemical Pharmacology 13: 1037–1051 (1964)
Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S. and Wilkinson, G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359 (1975).
Lumholtz, B.; Siersbaek-Nielsen, K.; Skovsted, L.; Kampmann, J.P. and Hansen, J.M.: Sulfamethizole induced inhibition of diphenylhydantoin, tolbutamide and warfarin metabolism. Clinical Pharmacology and Therapeutics 17: 731–734 (1975).
O’Malley, K.; Crooks, J.; Duke, E. and Stevenson, I.H.: Effects of age and sex on human drug metabolism. British Medical Journal 3: 607–609 (1971).
Pirttiaho, H.I.; Sotaniemi, E.A.; Ahokas, J.T. and Pitkänen, U.: Liver size indices of drug metabolism in epileptics. British Journal of Clinical Pharmacology 6: 273–278 (1978).
Rasmussen, S.N.: Liver volume determination by ultrasonic scanning. Danish Medical Bulletin 25: 1–48 (1978)
Rasmussen, S.N.; Hansen, J.M.; Kampmann, J.P.; Skovsted, L. and Bach, B.: Drug metabolism in relation to liver volume and age. Scandinavian Journal of Gastroenterology 11 (Suppl. 38): 82 (1976).
Roberts, C.J.C.; Jackson, L.; Halliwell, M. and Branch, R.A.: The relationship between liver volume, antipyrine clearance and indocyanin green clearance before and after phenobarbitone administration in man. British Journal of Clinical Pharmacology 3: 907–913 (1976).
Rodkey, F.L: Direct spectro-photometric determination of albumin in human serum. Clinical Chemistry 11: 478–487 (1965).
Sato, T.; Miwa, T. and Tauchi, H.: Age changes in the human liver of the different races. Geronlologia 16: 368–380 (1970).
Swift, C.C.; Homeida, M.; Halliwell, M. and Roberts, C.J.C.: Antipyrine disposition and liver size in the elderly. European Journal of Clinical Pharmacology 14: 149–152 (1978)
Traeger, A.; Kunze. H; Stein, G. and Ankermann, H.; Zur Pharmakokinetik von Indometazin bei alten Mänschen. Zeitschrift für Alternforschung 27: 151–155 (1973).
Triggs, E.J.; Nation, R.L.; Long, A. and Ashley, J.J.: Pharmacokinetics in the elderly. European Journal of Clinical Pharmacology 8: 55–62 (1974).
Vesell, E.S. and Page, J.G.: Genetic control of dicoumarol levels in man. Journal of Clinical Investigation 47: 2657–2663 (1968)
Vesell, E.S. and Page, J.G.: Genetic control of drug levels in man: Antipyrine. Science 161: 72–73 (1975)
Vestal, R.E.; Norris, A.H.; Tobin, J.D.; Cohen, B.H.; Shock, N.W. and Andres, R.: Antipyrine metabolism in man: Influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432 (1975).
Wilkinson, G.R.: The effects of ageing on the disposition of benzodiazepines in man; in Crooks and Stevenson (Eds) Drugs and the Elderly, pp 103–116 (Macmillan, London 1979)
Wilkinson, G.R. and Shand, D.G.: A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bach, B., Hansen, J.M., Kampmann, J.P. et al. Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in Man. Clin Pharmacokinet 6, 389–396 (1981). https://doi.org/10.2165/00003088-198106050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198106050-00005